| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 09/22/2010 | EP2229935A1 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition |
| 09/22/2010 | EP2229379A2 Solid forms of 1-ethyl-3-(5-(5-fluoropyridin-3-yl)-7-(pyrimidin-2-yl)-1h-benzo[d]imidazol-2-yl)urea |
| 09/22/2010 | EP2229378A1 Fluorescent, heterocyclic annellated perylene |
| 09/22/2010 | EP2229377A1 5-alkyl/alkenyl-3-cyanopyridines as kinase inhibitors |
| 09/22/2010 | EP2229376A1 Indole-substituted 3-cyanopyridines as kinase inhibitors |
| 09/22/2010 | EP2229375A1 Gamma secretase modulators |
| 09/22/2010 | EP2229368A1 Cyclic urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 09/22/2010 | EP2229363A1 Renin inhibitors |
| 09/22/2010 | EP2229358A1 Indoles and their therapeutic use |
| 09/22/2010 | EP2229356A1 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis |
| 09/22/2010 | EP2134704B1 Compounds and compositions as modulators of gpr119 activity |
| 09/22/2010 | EP2076506B1 Heterocyclic-substituted piperidines as orl-1 ligands |
| 09/22/2010 | EP2029552B1 Sulfimides as protein kinase inhibitors |
| 09/22/2010 | EP2021330B1 Benzimidazole modulators of vr1 |
| 09/22/2010 | EP1836163B1 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 09/22/2010 | EP1796669B1 Aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 09/22/2010 | EP1730135B1 Qiunolin-4-ones as inhibitors of retroviral integrase for the treatment of hiv, aids and aids related complex (arc) |
| 09/22/2010 | EP1692114B1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 09/22/2010 | EP1618092B1 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors |
| 09/22/2010 | EP1599464B1 Novel cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors |
| 09/22/2010 | CN1856484B Therapeutic agents useful for treating or preventing pain |
| 09/22/2010 | CN1788001B 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 09/22/2010 | CN101842361A Pyrazinone derivatives and their use in the treatment of lung diseases |
| 09/22/2010 | CN101842360A Anti-infective pyrimidines and uses thereof |
| 09/22/2010 | CN101842353A 2, 3-substituted indole derivatives for treating viral infections |
| 09/22/2010 | CN101838271A Bicyclic [3.1.0] derivatives as glycine transporter inhibitors |
| 09/22/2010 | CN101838261A Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 09/22/2010 | CN101838260A Dihydropyrrolones derivative as Caspase-3 inhibitor |
| 09/21/2010 | US7799931 Spirocyclic cyclohexane compounds |
| 09/21/2010 | US7799925 preparation of (S)-omeprazole from racemic omeprazole via the formation of an inclusion complex with (S)-1,1,2-triphenyl-1,2-ethanediol |
| 09/21/2010 | US7799924 Substituted homopiperidine, piperidine or pyrrolidine derivatives |
| 09/21/2010 | US7799917 for use as light-emissive layer in OLEDs (organic light emitting devices); iridium (III) complex of a 2-phenylpyridine ligand, where the pyridine and phenyl ring each have a 3,5-bis(p-alkoxyphenyl)phenyl substituent; ideal for solution processing such as spin coating, ink jet printing films |
| 09/21/2010 | US7799915 Several exemplified (pyrimidin-2-ylamino)benzenesulfonamide compounds such as N-phenyl-4-[(4-thien-2-ylpyrimidin-2-yl)amino]benzenesulfonamide; I kappa B kinase inhibitors (IKK inhibitors); anticancer agents, autoimmune diseases, osteoporosis |
| 09/21/2010 | US7799827 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis |
| 09/21/2010 | US7799819 chronic lymphocytic leukemia or acute lymphoblastic leukemia; use of specific compound (1R)-cyclopropanecarboxylic acid {2-[2-carbamoyl-1-(3-ethoxy-4-methoxy-phenyl)-ethyl]-7-chloro-3-oxo-2,3-dihydro-1H-isoindol-4-yl}-amide |
| 09/21/2010 | US7799809 N-(3-Amino-1-benzyl-2,3-dioxopropyl)-2-{3-[3-(trifluoromethyl)phenyl]-1H-pyrazol-1-yl}nicotinamide; neurodegenerative disorders, chronic brain supply deficit, ischemia (stroke) o brain trauma, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease |
| 09/21/2010 | US7799808 such as 2-bromo-1-[6-(4-methyl-imidazole-1-yl)-pyridin-3-yl]-ethanone, which have activity in modulating levels of amyloid-beta, useful in the treatment of neurodegenerative diseases, such as Alzheimer's disease |
| 09/21/2010 | US7799807 vanilloid receptor antagonists comprising phenylene compounds, used as analgesic |
| 09/21/2010 | US7799804 1,2-diarylimidazole-4-carboxamide compounds such as ethanesulfonic acid 4-[2-(2,4-dichlorophenyl)-5-methyl-4-(piperidin-1-ylcarbamoyl)-imidazol-1-yl]phenyl ester, used in the treatment of obesity, psychological and nervous system disorders |
| 09/21/2010 | US7799803 Hydroxamic acid compounds and methods of use thereof |
| 09/21/2010 | US7799801 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 09/21/2010 | US7799790 Morphological stabilized; using mixture of stabilizers |
| 09/21/2010 | US7799789 treating chemokine mediated diseases; inflammatory, autoimmune diseases; graft rejection, rheumatoid arthritis, multiple sclerosis, psoriasis, ophthalmic inflammation, type I diabetes, viral meningitis |
| 09/21/2010 | US7799787 pyridazine derivatives such as N-(2-Cyclopropylethyl)-6-{4-[2-(trifluoromethyl)phenoxy]piperidin-1-yl}pyridazine-3-carboxamide, useful for the prevention and treatment of dyslipidemia, obesity, diabetes, syndrome X, insulin resistance, fatty liver, cancer, cardiovascular and nervous system disorders |
| 09/21/2010 | US7799786 Therapeutic agents useful for treating pain |
| 09/21/2010 | US7799782 P38 inhibitors and methods of use thereof |
| 09/21/2010 | US7799778 5-substituted 2-aminopyridine analogs for treating allergic and inflammatory diseases |
| 09/21/2010 | US7799775 Pyrimidine derivatives |
| 09/21/2010 | US7799774 Quinoline derivatives and their use as 5-HT6 ligands |
| 09/21/2010 | US7799773 administering 7-Benzyloxy-3-cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine, for the treatment of Alzheimer's disease, cognitive impairment, dementia, epilepsy, neuropathic pain, Parkinson's disease, schizophrenia, attention deficit disorder or depression in humans |
| 09/21/2010 | US7799576 Using mass analysis to monitor concentration of analytes in fluids; electrophilic and chromatographic separation |
| 09/21/2010 | CA2538884C Quinazoline derivatives as tyrosine kinase inhibitors |
| 09/21/2010 | CA2521492C 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivative or salt thereof |
| 09/21/2010 | CA2481229C Substituted pyrazine inhibitors of akt |
| 09/21/2010 | CA2477720C Quinoline derivatives |
| 09/21/2010 | CA2473892C Novel quinoline derivatives |
| 09/21/2010 | CA2440559C Novel non-imidazole compounds |
| 09/21/2010 | CA2438593C Glucopyranosyloxypyrazole derivatives and medicinal use thereof |
| 09/21/2010 | CA2436225C N-(arylsulphonyl)beta-amino acid derivatives comprising a substituted aminomethyl group, process for preparing them and pharmaceutical compositions containing them |
| 09/21/2010 | CA2434178C Substituted amine derivatives and methods of use |
| 09/21/2010 | CA2428019C Estrogen receptor modulators |
| 09/21/2010 | CA2417148C Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation |
| 09/21/2010 | CA2359948C Triazole compounds with dopamine-d3-receptor affinity |
| 09/16/2010 | WO2010104899A1 Thiazole sulfonamide and oxazole sulfonamide kinase inhibitors |
| 09/16/2010 | WO2010104830A1 Pyridone analogs useful as melanin concentrating hormone receptor-1 antagonists |
| 09/16/2010 | WO2010104195A1 Novel isoindolin-1-one derivative |
| 09/16/2010 | WO2010104024A1 Piperazine compound capable of inhibiting prostaglandin d synthase |
| 09/16/2010 | WO2010103438A1 Substituted indazole amides and their use as glucokinase activators |
| 09/16/2010 | WO2010103333A1 Compounds for the treatment of metabolic disorders |
| 09/16/2010 | WO2010103297A2 Bis aromatic compounds for use as ltc4 synthase inhibitors |
| 09/16/2010 | WO2010103283A1 Bis aromatic compounds for use as ltc4 synthase inhibitors |
| 09/16/2010 | WO2010103279A1 Bis aromatic compounds for use as lct4 synthase inhibitors |
| 09/16/2010 | WO2010103278A1 Bis aromatic compounds for use as ltc4 synthase inhibitors |
| 09/16/2010 | WO2010102968A1 Indole derivatives as ikk2 inhibitors |
| 09/16/2010 | WO2010102809A1 Substituted nicotinamides as kcnq2/3 modulators |
| 09/16/2010 | WO2010077836A3 Pyrrolidine compounds which modulate the cb2 receptor |
| 09/16/2010 | WO2010065865A3 Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
| 09/16/2010 | WO2010065110A3 Antimicrobials |
| 09/16/2010 | WO2010059606A3 Inhibitors of diacylglycerol acyltransferase |
| 09/16/2010 | WO2010057118A3 Heterocyclic antagonists of prostaglandin d2 receptors |
| 09/16/2010 | WO2010054056A3 Nilotinib hci crystalline forms |
| 09/16/2010 | WO2010053583A3 Small molecule cd4 mimetics and uses thereof |
| 09/16/2010 | WO2009087238A3 Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies |
| 09/16/2010 | US20100234602 Novel r,r`-atracurium salts |
| 09/16/2010 | US20100234601 Transition metal catalyzed synthesis of 2H-indazoles |
| 09/16/2010 | US20100234599 Method for preparing acid addition salts of polyacidic basic compounds |
| 09/16/2010 | US20100234598 Process for the preparation of imatinib and intermediates thereof |
| 09/16/2010 | US20100234594 Inhibitor of binding of s1p1 |
| 09/16/2010 | US20100234435 Cycloalkylamino acid derivatives |
| 09/16/2010 | US20100234431 Pyrrolidine compounds |
| 09/16/2010 | US20100234428 Substituted 2-mercapto-3-aminopyridines as kcnq2/3 modulators |
| 09/16/2010 | US20100234426 Phenylpropionamide Compounds and the Use Thereof |
| 09/16/2010 | US20100234425 2-substituted-1h-benzimidazole-4-carboxamides are parp inhibitors |
| 09/16/2010 | US20100234424 Derivatives of n-phenyl(piperidine-2-yl) methyl benzamide preparation method thereof and applications of same in therapeutics |
| 09/16/2010 | US20100234422 Sulfonylated Heterocycles Useful for Modulation of the Progesterone Receptor |
| 09/16/2010 | US20100234410 Hydrate for medical purposes |
| 09/16/2010 | US20100234409 Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity |
| 09/16/2010 | US20100234406 Compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 09/16/2010 | US20100234405 Pyrimidine nucleoside derivatives and salts thereof |
| 09/16/2010 | US20100234395 Ureide derivative and pharmaceutical application thereof |